Central Asia vs Naoero: Proportion of the target population who received
Central Asia
97.0%
in 2024
Naoero
99.0%
in 2024
Central Asia rank
1st
Naoero rank
1st
Proportion of the target population who received over time
- Central Asia
- Naoero
How they compare
Naoero currently reports 99.0% against 97.0% in Central Asia, a difference of 2.0%.
The two have swapped places 4 times across 24 shared years of data; in 2001 it was Naoero ahead.
Central Asia ranks 1st and Naoero ranks 1st of 37 groups.
Across the 3 decades both report, Central Asia averaged higher in 2 and Naoero in 1.
Head to head by decade
| Decade | Central Asia | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.4% | 83.0% | 0.4% | Central Asia |
| 2010s | 96.5% | 93.7% | 2.8% | Central Asia |
| 2020s | 97.4% | 98.6% | 1.2% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Central Asia or Naoero?
- Naoero, at 99.0% against 97.0% in Central Asia as of 2024.
- What is the difference in proportion of the target population who received between Central Asia and Naoero?
- 2.0%, with Naoero ahead.
- How many years of comparable data are there for Central Asia and Naoero?
- 24 years are reported by both, from 2001 to 2024.
- How do Central Asia and Naoero rank globally for proportion of the target population who received?
- Central Asia ranks 1st and Naoero ranks 1st of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.